These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 31694417)
1. Cayero-Otero MD; Gomes MJ; Martins C; Álvarez-Fuentes J; Fernández-Arévalo M; Sarmento B; Martín-Banderas L Expert Opin Drug Deliv; 2019 Dec; 16(12):1413-1427. PubMed ID: 31694417 [No Abstract] [Full Text] [Related]
2. Nose-to-brain delivery of lamotrigine-loaded PLGA nanoparticles. Nigam K; Kaur A; Tyagi A; Nematullah M; Khan F; Gabrani R; Dang S Drug Deliv Transl Res; 2019 Oct; 9(5):879-890. PubMed ID: 30887226 [TBL] [Abstract][Full Text] [Related]
3. Intranasal delivery of Paclitaxel encapsulated nanoparticles for brain injury due to Glioblastoma. Zhang Y; Sun C; Zhang Q; Deng Y; Hu X; Chen P J Appl Biomater Funct Mater; 2020; 18():2280800020977170. PubMed ID: 33307944 [TBL] [Abstract][Full Text] [Related]
4. Targeted delivery of mannosylated-PLGA nanoparticles of antiretroviral drug to brain. Patel BK; Parikh RH; Patel N Int J Nanomedicine; 2018; 13(T-NANO 2014 Abstracts):97-100. PubMed ID: 29593405 [TBL] [Abstract][Full Text] [Related]
5. Development and evaluation of brain targeted intranasal alginate nanoparticles for treatment of depression. Haque S; Md S; Sahni JK; Ali J; Baboota S J Psychiatr Res; 2014 Jan; 48(1):1-12. PubMed ID: 24231512 [TBL] [Abstract][Full Text] [Related]
6. Functionalized PLGA nanoparticles prepared by nano-emulsion templating interact selectively with proteins involved in the transport through the blood-brain barrier. Monge M; Fornaguera C; Quero C; Dols-Perez A; Calderó G; Grijalvo S; García-Celma MJ; Rodríguez-Abreu C; Solans C Eur J Pharm Biopharm; 2020 Nov; 156():155-164. PubMed ID: 32927077 [TBL] [Abstract][Full Text] [Related]
7. Oxcarbazepine free or loaded PLGA nanoparticles as effective intranasal approach to control epileptic seizures in rodents. Musumeci T; Serapide MF; Pellitteri R; Dalpiaz A; Ferraro L; Dal Magro R; Bonaccorso A; Carbone C; Veiga F; Sancini G; Puglisi G Eur J Pharm Biopharm; 2018 Dec; 133():309-320. PubMed ID: 30399400 [TBL] [Abstract][Full Text] [Related]
9. Comparative evaluation of the degree of pegylation of poly(lactic-co-glycolic acid) nanoparticles in enhancing central nervous system delivery of loperamide. Kirby BP; Pabari R; Chen CN; Al Baharna M; Walsh J; Ramtoola Z J Pharm Pharmacol; 2013 Oct; 65(10):1473-81. PubMed ID: 24028614 [TBL] [Abstract][Full Text] [Related]
10. Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's disease mice model. Cano A; Ettcheto M; Chang JH; Barroso E; Espina M; Kühne BA; Barenys M; Auladell C; Folch J; Souto EB; Camins A; Turowski P; García ML J Control Release; 2019 May; 301():62-75. PubMed ID: 30876953 [TBL] [Abstract][Full Text] [Related]
12. Transferrin adsorption onto PLGA nanoparticles governs their interaction with biological systems from blood circulation to brain cancer cells. Chang J; Paillard A; Passirani C; Morille M; Benoit JP; Betbeder D; Garcion E Pharm Res; 2012 Jun; 29(6):1495-505. PubMed ID: 22167349 [TBL] [Abstract][Full Text] [Related]
13. Anti-proliferate and apoptosis triggering potential of methotrexate-transferrin conjugate encapsulated PLGA nanoparticles with enhanced cellular uptake by high-affinity folate receptors. Parmar A; Jain A; Uppal S; Mehta SK; Kaur K; Singh B; Sandhir R; Sharma S Artif Cells Nanomed Biotechnol; 2018; 46(sup2):704-719. PubMed ID: 29745729 [TBL] [Abstract][Full Text] [Related]
14. Enhanced cancer therapy with pH-dependent and aptamer functionalized doxorubicin loaded polymeric (poly D, L-lactic-co-glycolic acid) nanoparticles. Saravanakumar K; Hu X; Shanmugam S; Chelliah R; Sekar P; Oh DH; Vijayakumar S; Kathiresan K; Wang MH Arch Biochem Biophys; 2019 Aug; 671():143-151. PubMed ID: 31283911 [TBL] [Abstract][Full Text] [Related]
15. Investigation of imatinib loaded surface decorated biodegradable nanocarriers against glioblastoma cell lines: Intracellular uptake and cytotoxicity studies. Khan AM; Ahmad FJ; Panda AK; Talegaonkar S Int J Pharm; 2016 Jun; 507(1-2):61-71. PubMed ID: 27154254 [TBL] [Abstract][Full Text] [Related]
16. Intranasal administration of edaravone nanoparticles improves its stability and brain bioavailability. Lu Y; Wang JT; Li N; Zhu X; Li Y; Bansal S; Wang Y; Al-Jamal KT J Control Release; 2023 Jul; 359():257-267. PubMed ID: 37290723 [TBL] [Abstract][Full Text] [Related]
17. Intranasal delivery of rotigotine to the brain with lactoferrin-modified PEG-PLGA nanoparticles for Parkinson's disease treatment. Bi C; Wang A; Chu Y; Liu S; Mu H; Liu W; Wu Z; Sun K; Li Y Int J Nanomedicine; 2016; 11():6547-6559. PubMed ID: 27994458 [TBL] [Abstract][Full Text] [Related]
18. Comparative receptor based brain delivery of tramadol-loaded poly(lactic-co-glycolic acid) nanoparticles. Lalani J; Raichandani Y; Mathur R; Lalan M; Chutani K; Mishra AK; Misra A J Biomed Nanotechnol; 2012 Dec; 8(6):918-27. PubMed ID: 23030000 [TBL] [Abstract][Full Text] [Related]
19. Small molecule delivery to solid tumors with chitosan-coated PLGA particles: A lesson learned from comparative imaging. Park J; Pei Y; Hyun H; Castanares MA; Collins DS; Yeo Y J Control Release; 2017 Dec; 268():407-415. PubMed ID: 29111150 [TBL] [Abstract][Full Text] [Related]
20. Nose to Brain Delivery of Transferrin conjugated PLGA nanoparticles for clonidine. Sharma S; Tyagi A; Dang S Int J Biol Macromol; 2023 Dec; 252():126471. PubMed ID: 37619678 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]